Methyl iodide → HCID 71252000, compound
Reaction equation
[CH3:1][C:2]1[C:3]([N:10]2[CH2:15][CH2:14][N:13]([C:16]([C:18]3[N:23]=[CH:22][C:21]([N:24]4[CH2:28][CH2:27][NH:26][C:25]4=[O:29])=[CH:20][CH:19]=3)=[O:17])[CH2:12][CH2:11]2)=[N:4][C:5]([CH3:9])=[C:6]([CH3:8])[CH:7]=1.[CH3:30]I>>[CH3:30][N:26]1[CH2:27][CH2:28][N:24]([C:21]2[CH:22]=[N:23][C:18]([C:16]([N:13]3[CH2:12][CH2:11][N:10]([C:3]4[C:2]([CH3:1])=[CH:7][C:6]([CH3:8])=[C:5]([CH3:9])[N:4]=4)[CH2:15][CH2:14]3)=[O:17])=[CH:19][CH:20]=2)[C:25]1=[O:29]Participants
3
Procedure
Using 1-{6-[4-(3,5,6-trimethylpyridin-2-yl)piperazine-1-carbonyl]pyridin-3-yl}imidazolidin-2-one (136 mg) described in Example 397 and methyl iodide (26 μL) and by the reaction and treatment in the same manner as in Example 36, the title compound (109 mg) was obtained.
Sources & evidence
- ORD record
- ord-f3682e2105b140cca538eb8d18383e33
- Source dataset
- uspto-grants-2014_08
- Patent number
- US08816079B2
Reaction notes
Loading…